Menu

Located in New Haven, Connecticut, Yale Cancer Center is a collaborative effort between two highly respected organizations: the Yale School of Medicine, a well-known medical school and Smilow Cancer Hospital at Yale-New Haven.

It’s impossible to think about cancer treatment today without touching on a treatment that was pioneered at Yale University, namely, chemotherapy. Cancer chemotherapy and cancer drug development was discovered at Yale, and the first-ever cancer drug was administered there in 1942. The university has also played a role in other cancer milestones. As far back as the early 1900s, a Yale doctor developed a method for growing tumor cells, an important step in understanding how tumors develop. Later, the first FDA-approved selective immunotherapy treatment for cancer was developed at the university.

Over the past four decades, the center has grown into a powerhouse for research, technology and clinical care.Its successes are rooted in research. By emphasizing the molecular origins of cancer, the Yale Cancer Center promotes treatments that are created for specific types of cancers. Through this process, which the center calls “personalized medicine,” the patient can expect more targeted treatments and fewer side effects. In recent years, Yale Cancer Center has seen its facilities brought up to par with its reputation. In 2009, Yale-New Haven Hospital opened a 14-story, state-of-the-art facility specifically designed for the delivery of cancer treatment.

In terms of the treatment of mesothelioma, Yale understands and supports the common treatments of surgery, radiation therapy and chemotherapy. They strive to use a multidisciplinary approach with a team of medical oncologists, radiation oncologists and surgeons. They also support the use of clinical trials if it’s in the best interest of the patient and their particular case.

Specializations:

  • Multimodal treatment
  • Clinical trials
  • Mesothelioma and other asbestos-related conditions

Accreditations:

  • Connecticut Magazine Best Doctors recognition

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors


Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Breast Neoplasms, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Germinoma, Ovarian Neoplasms, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Carcinoid Tumor, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Seminoma, Pheochromocytoma, Choriocarcinoma, Cystadenocarcinoma, Neoplasms, Second Primary, Carcinoma, Endometrioid, Cystadenocarcinoma, Serous, Chordoma, Paraganglioma, Carotid Body Tumor, Hemangiosarcoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Adenocarcinoma, Mucinous, Adenocarcinoma, Clear Cell, Nerve Sheath Neoplasms, Neurofibrosarcoma, Testicular Neoplasms, Cystadenocarcinoma, Mucinous, Fibroma, Salivary Gland Neoplasms, Carcinoma, Ductal, Thyroid Neoplasms, Pseudomyxoma Peritonei, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Vulvar Neoplasms, Rare Diseases, Adenocarcinoma, Papillary, Fibromatosis, Aggressive, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Carcinoma, Giant Cell, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Hydatidiform Mole, Invasive, Pituitary Neoplasms, Neoplasms, Unknown Primary, Odontogenic Tumors

Last Updated: July 22, 2019

Status: Recruiting

Photo of Yale Cancer Center

Get Help Contacting Yale Cancer Center


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe